Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-26-000008

PRESIDENT AND COO sold 22,500 shares at $470.95 ($10,596,429)

  • PRESIDENT AND COO acquired 22,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Exercise or conversion : show line 1 in the form 10b5-1 +14,625 $117.76 $1,722,240 14,625 I
2026-02-02 Sale : show line 2 in the form 10b5-1 −14,625 $470.95 $6,887,679 0 I
2026-02-02 Exercise or conversion : show line 3 in the form 10b5-1 +7,875 $146.03 $1,149,986 7,875 I
2026-02-02 Sale : show line 4 in the form 10b5-1 −7,875 $470.95 $3,708,750 0 I
Open-market sales · 22,500 sh · avg $470.95 · $10,596,429

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-02 Exercise or conversion : show line 5 in the form 10b5-1 Stock Options −14,625 38,625 I
2026-02-02 Exercise or conversion : show line 6 in the form 10b5-1 Stock Options −7,875 20,815 I
Loading xslF345X05/primarydocument.xml…